Source: International Congress 2015 – COPD: interesting notes
Disease area: Airway diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Begüm Ergan (Izmir, Turkey), Recai Ergun, Begum Ergan. Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations?. Eur Respir J 2015; 46: Suppl. 59, 395

Member's Comments

No comment yet.

Related content which might interest you: Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Serum uric acid as a predictor of mortality and future exacerbations of COPD Source: Eur Respir J 2014; 43: 43-53 Year: 2004 CRP as predictor as predictor for late treatment failure in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 COPD: Plasma surfactant protein-D (SPD) concentration as a predictor of acute exacerbations (AE) probability Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Serum periostin in patients hospitalized for COPD exacerbations Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 BNP level in patients with COPD exacerbations Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 LATE-BREAKING ABSTRACT: Validation of the DECAF score to predict hospital mortality in exacerbations of COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Assessment of serum uric acid in COPD exacerbations Source: International Congress 2017 – Markers of COPD progression Year: 2017 Predictive factors of 90-days post-discharge COPD acute exacerbation’s recurrence Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 High urea levels predict long term mortality in patients hospitalised for acute exacerbation of COPD Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014 Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Midrange-proadrenomedullin in stable state predicts severe exacerbation of COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Assessment of malondialdehyde in the airways during treatment of COPD exacerbations Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016